Gerri Henwood
2019 - Recro Pharma
In 2019, Gerri Henwood earned a total compensation of $4.6M as President and Chief Executive Officer at Recro Pharma, a 90% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $360,000 |
|---|---|
| Option Awards | $1,062,199 |
| Salary | $553,846 |
| Stock Awards | $2,608,537 |
| Other | $38,402 |
| Total | $4,622,984 |
Henwood received $2.6M in stock awards, accounting for 56% of the total pay in 2019.
Henwood also received $360K in non-equity incentive plan, $1.1M in option awards, $553.8K in salary and $38.4K in other compensation.
Rankings
In 2019, Gerri Henwood's compensation ranked 2,455th out of 13,971 executives tracked by ExecPay. In other words, Henwood earned more than 82.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,455 out of 13,971 | 82nd |
Division Manufacturing | 881 out of 5,695 | 85th |
Major group Chemicals And Allied Products | 286 out of 2,194 | 87th |
Industry group Drugs | 230 out of 1,880 | 88th |
Industry Pharmaceutical Preparations | 169 out of 1,392 | 88th |
Source: SEC filing on March 27, 2020.
Henwood's colleagues
We found three more compensation records of executives who worked with Gerri Henwood at Recro Pharma in 2019.
News
Baudax Bio CEO Gerri Henwood's 2021 pay jumps 178% to $1.7M
March 31, 2022
Recro Pharma CFO Ryan Lake's 2020 pay jumps 161% to $2.2M
March 25, 2021
Baudax Bio CEO Gerri Henwood's 2020 pay falls 87% to $603K
March 11, 2021
Recro Pharma CEO Gerri Henwood's 2019 pay jumps 90% to $4.6M
March 27, 2020
Recro Pharma CEO Gerri Henwood's 2018 pay rises 16% to $2.4M
March 20, 2019